Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.


TSX:MBX - Post by User

Comment by prophetoffactzon Nov 17, 2023 8:57am
127 Views
Post# 35740788

RE:RE:New Press Release - Microbix Presenting at Florida Capital Event Conference

RE:RE:New Press Release - Microbix Presenting at Florida Capital Event Conference
rjc7 wrote: All of these new Investment Conferences that MBX presents at, (in this case 18 one-on-ones with growth investment companies), will start to take on new meaning.


Especially if they can firm up a understanding of where the base business is. They might have felt a need to address that recently with the weakness in the stock. Today we get an update...

"Microbix will update shareholders about Kinlytic, the Agreement, and its overall operations via a webinar hosted by Adelaide Capital at 10:00 AM ET on Friday, November 17, 2023. Participants can register" here: https://us02web.zoom.us/webinar/register/WN_ssbGvk0gT9arZNyp6BkHcQ.

<< Previous
Bullboard Posts
Next >>